🍽️ allopurinol,(prescription)

AI Engines For more Details: Perplexity Kagi Labs You

Xanthine Oxidase Inhibition: Allopurinol works by inhibiting the enzyme xanthine oxidase, which is responsible for the conversion of hypoxanthine and xanthine to uric acid. By blocking this enzyme, allopurinol reduces the production of uric acid, leading to decreased serum urate levels.
Treatment of Gout: Allopurinol is a first-line medication for the management of gout, a form of inflammatory arthritis caused by the deposition of monosodium urate crystals in the joints. By lowering serum urate levels, allopurinol helps prevent the formation of urate crystals and reduces the frequency and severity of gout attacks.
Prevention of Gout Flares: Allopurinol is also used for the long-term prevention of gout flares in patients with recurrent gout attacks or tophi (urate crystal deposits) despite dietary modifications or lifestyle changes. Continuous allopurinol therapy helps maintain serum urate levels within the target range and prevents the recurrence of gout symptoms.
Prevention of Uric Acid Kidney Stones: Allopurinol may be used to prevent the formation of uric acid kidney stones in individuals with a history of recurrent kidney stones related to hyperuricosuria (excessive urinary excretion of uric acid). By lowering urinary uric acid levels, allopurinol reduces the risk of uric acid stone formation.
Treatment of Hyperuricemia: Allopurinol is indicated for the treatment of asymptomatic hyperuricemia in patients at risk of developing gout or uric acid kidney stones. By lowering serum urate levels, allopurinol helps prevent the progression of hyperuricemia to symptomatic gout or other complications.
Allopurinol Hypersensitivity Syndrome (AHS): A rare but potentially serious side effect of allopurinol therapy is allopurinol hypersensitivity syndrome (AHS), also known as drug reaction with eosinophilia and systemic symptoms (DRESS). AHS is characterized by fever, rash, eosinophilia, and multiorgan involvement, including hepatitis, nephritis, and hematologic abnormalities. Patients with a history of AHS should not be rechallenged with allopurinol.
Renal Function: Allopurinol is primarily eliminated by the kidneys, and dosage adjustments may be necessary in patients with impaired renal function to prevent drug accumulation and potential toxicity. Renal function should be monitored regularly during allopurinol therapy, particularly in elderly patients or those with pre-existing renal impairment.
Hypersensitivity Reactions: Apart from AHS, allopurinol may cause other hypersensitivity reactions, including skin rash, pruritus, and mild gastrointestinal symptoms. Patients should be monitored for signs of hypersensitivity, and therapy should be discontinued if a severe allergic reaction occurs.
Drug Interactions: Allopurinol may interact with certain medications, including azathioprine, mercaptopurine, and theophylline, among others. Concurrent use of these medications with allopurinol may increase the risk of adverse effects or alter their therapeutic efficacy. Close monitoring and dosage adjustments may be necessary when combining allopurinol with other drugs.

;

Check for interactions on Supp.AI | 📚 PubMed Citations

(a.p.n., acpurin, adco-allopurinol, al, alfadiman, allo x, allobeta, allocor, allo-ct, allonol, allopac, allopin, alloprim, allopsel, allopur, allopurine, allopurinol, allopurinol - 1 a pharma, allopurinol abz, allopurinol accord, allopurinol actavis, allopurinol al, allopurinol alpharma, allopurinol apotex, allopurinol arena, allopurinol arrow, allopurinol aurobindo, allopurinol biogaran, allopurinol btt, allopurinol cf, allopurinol chemiphar, allopurinol chen ta, allopurinol cherubino, allopurinol community pharm, allopurinol cp, allopurinol craveri, allopurinol crescent, allopurinol dak, allopurinol dha, allopurinol dosa, allopurinol dura, allopurinol eg, allopurinol fabra, allopurinol g.l., allopurinol gador, allopurinol genericon retard, allopurinol helvepharm, allopurinol hexal, allopurinol hexpharm, allopurinol hisun, allopurinol hovid, allopurinol inca, allopurinol isomed, allopurinol kyorin rimedio, allopurinol kyowa yakuhin, allopurinol landson, allopurinol meider, allopurinol mylan, allopurinol nichi-iko, allopurinol nordic drugs, allopurinol nycomed, allopurinol panbiotic, allopurinol pch, allopurinol pharmacare, allopurinol phoenix, allopurinol phr lab, allopurinol quality pharm, allopurinol ranbaxy, allopurinol ratiopharm, allopurinol retard, allopurinol sandoz, allopurinol sawai, allopurinol showa yakuhin kako, allopurinol sic, allopurinol stada, allopurinol standard, allopurinol takata, allopurinol teva, allopurinol towa, allopurinol u.c. pharma, allopurinol wockhardt, allopurinol yung shin, allopurinol ze, allopurinol zentiva, allopurinol zydus, allopurinol-egis, allopurinol-hisun, allopurinol-mepha, allopurinolo molteni, allopurinolo sandoz, allopurinolo teva italia, allopurinol-ratiopharm, allopurinol-teva, alloric, alloril, allorin, allostad, allozym, allupol, allurase, alluric, allurit, alodagra, alodan, alofar, aloprinol, alopron, alopurinol, alopurinol andromaco, alopurinol belupo, alopurinol chemopharma, alopurinol ciclum, alopurinol cinfa, alopurinol ecuaquímica, alopurinol hemofarm, alopurinol kern pharma, alopurinol merck, alopurinol mintlab, alopurinol mundogen, alopurinol nifa, alopurinol normon, alopurinol pensa, alopurinol pharmas, alopurinol ratiopharm, alopurinol sandoz, alopurinol teva, aloric, alositol, alpurase, alputon, aluric, alurin, alurol, aluron, anoprolin, anpurin, ao mai bi li, apllinol, apo allopurinol, apo-allopurinol, artrex, arythmet, atisuril, aurinol, benoxuric, capurate, cellidrin, colpuril, crystasol, darinol, decasurik, dertrifort, deurinol, duric, enpurol, esloric, etindrax, gichtex retard, goutex, gylonol, hexanurat, high pure, ifonol, isoric, ketobun, khotongfeng, korea united allopurinol, lessuric, licoric, linogra, llanol, lodiric, logout, logout-sr, lonol pt 300, lopric, loric, loricid, lu bi li, masaton, mephanol, milurit, miniplanor, neufan, nilapur, no uric, no-uric, ponuric, prinol, pritanol, prodec, progout, puribel, puricemia, puricos, purinase, puritenk, riball, ridonra, rinolic, ripunin, salobel, sandoz allopurinol, sinoric, stradumel, synol, synorid, takanarumin, talol, tonsaric, tylonic, ucorex, upha allopurinol, uranid, uric, uric pure, urica, uricemil, uricnol, uriconorm, ürikoliz, urinol, uriprim, urisal, urocuad, urogotan a, uropril, uroquad, urosin, valeric, xandase, xanturic, xuric-a, xylonol, yi da tong, zurim, zylapour, zyloprim, zylopurinol, zyloric, zyngot, zyprinol, acepurin, allopurinol sodium bedford, aloprim)

Data Contradictions — Limits of Certainity

Impacted of allopurinol,(prescription) On Probiotics

Rank	Probiotic	Impact
species	Bacteroides uniformis	Reduces
species	Blautia hansenii	Reduces
species	Escherichia coli	Reduces

Bacteria Impacted by allopurinol,(prescription)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

🧙?
📓 Direct Citations	👪👶 Indirect Citations	Taxonomy	Rank	Effect
0	1	Bilophila	genus	Decreases
0	1	Collinsella	genus	Decreases
0	1	Bacteroides	genus	Decreases
0	1	Escherichia	genus	Decreases
0	1	Streptococcus	genus	Decreases
0	1	Phocaeicola	genus	Decreases
0	1	Lacrimispora	genus	Decreases
0	1	Mediterraneibacter	genus	Decreases
0	1	Fusobacterium	genus	Decreases
0	1	Shigella	genus	Decreases
0	1	Roseburia	genus	Decreases
0	1	Parolsenella	genus	Decreases
0	1	Parabacteroides	genus	Decreases
0	1	Coprococcus	genus	Decreases
0	1	Eggerthella	genus	Decreases
0	1	Escherichia coli O1:K1:H7	no rank	Decreases
0	1	Escherichia coli O139:H1	no rank	Decreases
0	1	Escherichia coli O141:H4	no rank	Decreases
0	1	Escherichia coli O145:H34	no rank	Decreases
0	1	Escherichia coli O15:H12	no rank	Decreases
0	1	Escherichia coli O155:H21	no rank	Decreases
0	1	Escherichia coli O158:H23	no rank	Decreases
0	1	Escherichia coli O16:H48	no rank	Decreases
0	1	Escherichia coli O170:H18	no rank	Decreases
0	1	Escherichia coli O18ac:H14	no rank	Decreases
0	1	Escherichia coli O19:H7	no rank	Decreases
0	1	Escherichia coli O2:K1:H4	no rank	Decreases
0	1	Escherichia coli O2:K1:H5	no rank	Decreases
0	1	Escherichia coli O2:K1:H7	no rank	Decreases
0	1	Escherichia coli O20:H12	no rank	Decreases
0	1	Escherichia coli O25:H16	no rank	Decreases
0	1	Escherichia coli O55:H7	no rank	Decreases
0	1	Escherichia coli O68:H12	no rank	Decreases
0	1	Escherichia coli O7:H15	no rank	Decreases
0	1	Escherichia coli O78:H51	no rank	Decreases
0	1	Escherichia coli O80:H26	no rank	Decreases
0	1	Escherichia coli O84:H7	no rank	Decreases
0	1	Escherichia coli O85:H1	no rank	Decreases
0	1	Escherichia coli O103	serogroup	Decreases
0	1	Escherichia coli O111	serogroup	Decreases
0	1	Escherichia coli O119	serogroup	Decreases
0	1	Escherichia coli O121	serogroup	Decreases
0	1	Escherichia coli O145	serogroup	Decreases
0	1	Escherichia coli O155	serogroup	Decreases
0	1	Escherichia coli O157	serogroup	Decreases
0	1	Escherichia coli O177	serogroup	Decreases
0	1	Escherichia coli O26	serogroup	Decreases
0	1	Escherichia coli O3	serogroup	Decreases
0	1	Escherichia coli O43	serogroup	Decreases
0	1	Escherichia coli O5	serogroup	Decreases
0	1	Escherichia coli O78	serogroup	Decreases
0	1	Escherichia coli O86	serogroup	Decreases
0	1	Escherichia coli O91	serogroup	Decreases
0	1	Escherichia coli H20	serotype	Decreases
0	1	Escherichia coli O1:H42	serotype	Decreases
0	1	Escherichia coli O1:HNT	serotype	Decreases
0	1	Escherichia coli O10:H32	serotype	Decreases
0	1	Escherichia coli O10:K5(L):H4	serotype	Decreases
0	1	Escherichia coli O100:H21	serotype	Decreases
0	1	Escherichia coli O103:H11	serotype	Decreases
0	1	Escherichia coli O103:H2	serotype	Decreases
0	1	Escherichia coli O103:H25	serotype	Decreases
0	1	Escherichia coli O104:H21	serotype	Decreases
0	1	Escherichia coli O104:H4	serotype	Decreases
0	1	Escherichia coli O111:H-	serotype	Decreases
0	1	Escherichia coli O111:H11	serotype	Decreases
0	1	Escherichia coli O111:H8	serotype	Decreases
0	1	Escherichia coli O111:NM	serotype	Decreases
0	1	Escherichia coli O112ab:H8	serotype	Decreases
0	1	Escherichia coli O112ac:H19	serotype	Decreases
0	1	Escherichia coli O113:H21	serotype	Decreases
0	1	Escherichia coli O114:H49	serotype	Decreases
0	1	Escherichia coli O118:H16	serotype	Decreases
0	1	Escherichia coli O121:H19	serotype	Decreases
0	1	Escherichia coli O121:H7	serotype	Decreases
0	1	Escherichia coli O123:H11	serotype	Decreases
0	1	Escherichia coli O125ac:K+:H10	serotype	Decreases
0	1	Escherichia coli O126:H45	serotype	Decreases
0	1	Escherichia coli O127:H27	serotype	Decreases
0	1	Escherichia coli O127:H6	serotype	Decreases
0	1	Escherichia coli O128:H2	serotype	Decreases
0	1	Escherichia coli O128ac:H12	serotype	Decreases
0	1	Escherichia coli O139:H28	serotype	Decreases
0	1	Escherichia coli O145:H25	serotype	Decreases
0	1	Escherichia coli O145:H28	serotype	Decreases
0	1	Escherichia coli O145:NM	serotype	Decreases
0	1	Escherichia coli O146:H21	serotype	Decreases
0	1	Escherichia coli O15:H18	serotype	Decreases
0	1	Escherichia coli O150:H6	serotype	Decreases
0	1	Escherichia coli O152:H23	serotype	Decreases
0	1	Escherichia coli O153:H2	serotype	Decreases
0	1	Escherichia coli O156:H25	serotype	Decreases
0	1	Escherichia coli O157:H-	serotype	Decreases
0	1	Escherichia coli O157:H43	serotype	Decreases
0	1	Escherichia coli O157:H7	serotype	Decreases
0	1	Escherichia coli O157:NM	serotype	Decreases
0	1	Escherichia coli O16:H6	serotype	Decreases
0	1	Escherichia coli O165:H25	serotype	Decreases
0	1	Escherichia coli O167:H26	serotype	Decreases
0	1	Escherichia coli O174:H2	serotype	Decreases
0	1	Escherichia coli O174:H21	serotype	Decreases
0	1	Escherichia coli O174:H8	serotype	Decreases
0	1	Escherichia coli O176:H45	serotype	Decreases
0	1	Escherichia coli O177:NM	serotype	Decreases
0	1	Escherichia coli O2:H6	serotype	Decreases
0	1	Escherichia coli O2:K2:H1	serotype	Decreases
0	1	Escherichia coli O25:H1	serotype	Decreases
0	1	Escherichia coli O25:NM	serotype	Decreases
0	1	Escherichia coli O26:H1	serotype	Decreases
0	1	Escherichia coli O26:H11	serotype	Decreases
0	1	Escherichia coli O28ac:NM	serotype	Decreases
0	1	Escherichia coli O29:H4	serotype	Decreases
0	1	Escherichia coli O32:H37	serotype	Decreases
0	1	Escherichia coli O39:NM	serotype	Decreases
0	1	Escherichia coli O44:H18	serotype	Decreases
0	1	Escherichia coli O45:H2	serotype	Decreases
0	1	Escherichia coli O6:H16	serotype	Decreases
0	1	Escherichia coli O6:H16:CFA/II	serotype	Decreases
0	1	Escherichia coli O6:K2:H1	serotype	Decreases
0	1	Escherichia coli O69:H11	serotype	Decreases
0	1	Escherichia coli O7:H4	serotype	Decreases
0	1	Escherichia coli O7:K1	serotype	Decreases
0	1	Escherichia coli O78:H12	serotype	Decreases
0	1	Escherichia coli O78:H4	serotype	Decreases
0	1	Escherichia coli O79:H7	serotype	Decreases
0	1	Escherichia coli O8:H8	serotype	Decreases
0	1	Escherichia coli O81:NM	serotype	Decreases
0	1	Escherichia coli O83:H1	serotype	Decreases
0	1	Escherichia coli O86:H34	serotype	Decreases
0	1	Escherichia coli O89m:H10	serotype	Decreases
0	1	Escherichia coli O89m:H9	serotype	Decreases
0	1	Escherichia coli O9:H10	serotype	Decreases
0	1	Escherichia coli O91:H14	serotype	Decreases
0	1	Escherichia coli O91:NM	serotype	Decreases
0	1	Escherichia coli O99:H6	serotype	Decreases
0	1	Escherichia coli ONT:H33	serotype	Decreases
1	0	Streptococcus parasanguinis	species	Decreases
1	0	Bacteroides uniformis	species	Decreases
1	0	Bacteroides caccae	species	Decreases
1	0	Mediterraneibacter gnavus	species	Decreases
1	0	Bilophila wadsworthia	species	Decreases
1	0	Collinsella aerofaciens	species	Decreases
1	0	Escherichia coli	species	Decreases
1	0	Phocaeicola vulgatus	species	Decreases
1	0	Lacrimispora saccharolytica	species	Decreases
1	0	Streptococcus salivarius	species	Decreases
1	0	Fusobacterium nucleatum	species	Decreases
1	0	Roseburia intestinalis	species	Decreases
0	1	Streptococcus sp. LPB0220	species	Decreases
0	1	Streptococcus sp. HSISM1	species	Decreases
0	1	Bacteroides humanifaecis	species	Decreases
1	0	Parabacteroides merdae	species	Decreases
0	1	Shigella dysenteriae	species	Decreases
0	1	Streptococcus sp. FDAARGOS_192	species	Decreases
0	1	Blautia argi	species	Decreases
0	1	Parolsenella catena	species	Decreases
0	1	Shigella flexneri	species	Decreases
0	1	Escherichia albertii	species	Decreases
0	1	Bacteroides sp. CACC 737	species	Decreases
0	1	Escherichia fergusonii	species	Decreases
0	1	Shigella boydii	species	Decreases
1	0	Bacteroides fragilis	species	Decreases
0	1	Bacteroides sp. HF-162	species	Decreases
0	1	Bacteroides sp. A1C1	species	Decreases
0	1	Streptococcus lactarius	species	Decreases
0	1	Streptococcus gordonii	species	Decreases
0	1	Parolsenella massiliensis	species	Decreases
0	1	Streptococcus vestibularis	species	Decreases
0	1	Collinsella stercoris	species	Decreases
1	0	Coprococcus comes	species	Decreases
0	1	Streptococcus australis	species	Decreases
0	1	Blautia hansenii	species	Decreases
0	1	Streptococcus sp. oral taxon 061	species	Decreases
0	1	Shigella sonnei	species	Decreases
0	1	Blautia parvula	species	Decreases
0	1	Streptococcus infantis	species	Decreases
0	1	Escherichia marmotae	species	Decreases
0	1	Bacteroides faecium	species	Decreases
0	1	Streptococcus oralis	species	Decreases
0	1	Blautia producta	species	Decreases
0	1	Alistipes sp. dk3624	species	Decreases
0	1	Escherichia sp. E4742	species	Decreases
0	1	Thomasclavelia ramosa	species	Decreases
0	1	Streptococcus cristatus	species	Decreases
0	1	Bacteroides luhongzhouii	species	Decreases
0	1	Streptococcus sp. oral taxon 431	species	Decreases
0	1	Enterocloster bolteae	species	Decreases
0	1	Anaerostipes caccae	species	Decreases
0	1	Bacteroides caecimuris	species	Decreases
0	1	Lancefieldella parvula	species	Decreases
0	1	Streptococcus sp. Marseille-Q6470	species	Decreases
0	1	Bacteroides helcogenes	species	Decreases
0	1	Streptococcus koreensis	species	Decreases
0	1	Parafannyhessea umbonata	species	Decreases
0	1	Streptococcus ilei	species	Decreases
1	0	Eggerthella lenta	species	Decreases
1	0	[Ruminococcus] torques	species	Decreases
0	1	Fusobacterium nucleatum subsp. nucleatum	subspecies	Decreases

Impact of allopurinol,(prescription) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition	Positive Impact	Negative Impact	Benefit Ratio Impact
Abdominal Aortic Aneurysm	0.3		0.3
ADHD	1.3	0.1	12
Age-Related Macular Degeneration and Glaucoma	0.2	0.1	1
Allergic Rhinitis (Hay Fever)	1.5	1.4	0.07
Allergies	1.9	0.4	3.75
Allergy to milk products	1.1	0.6	0.83
Alopecia (Hair Loss)	0.3		0.3
Alzheimer's disease	2.6	2.8	-0.08
Amyotrophic lateral sclerosis (ALS) Motor Neuron	0.7	0.5	0.4
Ankylosing spondylitis	1.7	1	0.7
Anorexia Nervosa	0.4	0.8	-1
Antiphospholipid syndrome (APS)	1.1	0.3	2.67
Asthma	1.9	0.7	1.71
Atherosclerosis	1.4	0.5	1.8
Atrial fibrillation	0.9	1.1	-0.22
Autism	3.3	2.8	0.18
Autoimmune Disease	0.7	0.2	2.5
Barrett esophagus cancer	0.2	0.2	0
benign prostatic hyperplasia	0.4	0.3	0.33
Biofilm	2.3		2.3
Bipolar Disorder	1.1	0.3	2.67
Brain Trauma	0.5	0.4	0.25
Breast Cancer	0.8		0.8
Cancer (General)	0.2	0.6	-2
Carcinoma	2	0.6	2.33
Celiac Disease	1.9	0.7	1.71
Cerebral Palsy	0.5	0.4	0.25
Chronic Fatigue Syndrome	2.7	1.9	0.42
Chronic Kidney Disease	2.3	0.8	1.87
Chronic Lyme		0.4	-0.4
Chronic Obstructive Pulmonary Disease (COPD)	2.1	0.6	2.5
Chronic Urticaria (Hives)	1	0.2	4
Coagulation / Micro clot triggering bacteria	1.3	0.4	2.25
Cognitive Function	0.9	0.4	1.25
Colorectal Cancer	4.5	1.4	2.21
Constipation	1.1	0.2	4.5
Coronary artery disease	2	0.7	1.86
COVID-19	4	4	0
Crohn's Disease	4.9	1.2	3.08
Cushing's Syndrome (hypercortisolism)		0.7	-0.7
cystic fibrosis	0.8	0.4	1
d-lactic acidosis (one form of brain fog)	0.5		0.5
deep vein thrombosis	1.5	0.7	1.14
Denture Wearers Oral Shifts	0.9		0.9
Depression	5.3	2.9	0.83
Dermatomyositis	0.2		0.2
Eczema	1.4	0.8	0.75
Endometriosis	1.6	0.7	1.29
Eosinophilic Esophagitis	0.2	0.2	0
Epilepsy	2	0.7	1.86
erectile dysfunction	0.8		0.8
Fibromyalgia	0.7	1	-0.43
Functional constipation / chronic idiopathic constipation	2.5	1.4	0.79
gallstone disease (gsd)	1.7	0.3	4.67
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus	1.1	0.2	4.5
Generalized anxiety disorder	2.3	0.6	2.83
Glioblastoma		0.2	-0.2
Gout	1.1	0.2	4.5
Graves' disease	0.6	0.9	-0.5
Gulf War Syndrome	0.3	0.2	0.5
Halitosis	1	0.2	4
Hashimoto's thyroiditis	0.8	0.6	0.33
Heart Failure	2.6	0.2	12
hemorrhagic stroke	0.3		0.3
Hidradenitis Suppurativa	0.9		0.9
High Histamine/low DAO	0.7		0.7
hypercholesterolemia (High Cholesterol)	0.5		0.5
hyperglycemia	1.5	0.4	2.75
Hyperlipidemia (High Blood Fats)	0.5	0.3	0.67
hypersomnia		0.5	-0.5
hypertension (High Blood Pressure	1.6	1.2	0.33
Hypothyroidism		0.1	-0.1
Hypoxia	0.4		0.4
IgA nephropathy (IgAN)	0.8	1.4	-0.75
Inflammatory Bowel Disease	4.5	3	0.5
Insomnia	0.9	0.8	0.13
Intelligence	1.4		1.4
Intracranial aneurysms	0.6	0.3	1
Irritable Bowel Syndrome	3.2	2.2	0.45
ischemic stroke	1.1	0.8	0.38
Liver Cirrhosis	2.6	1.7	0.53
Long COVID	3.3	1.8	0.83
Low bone mineral density		0.2	-0.2
Lung Cancer	1.3		1.3
Lymphoma	0.4		0.4
Mast Cell Issues / mastitis	1	0.1	9
ME/CFS with IBS	0.5	0.4	0.25
ME/CFS without IBS	1	0.3	2.33
membranous nephropathy	0.2		0.2
Menopause	0.2	0.2	0
Metabolic Syndrome	5	2.5	1
Mood Disorders	4.5	2.6	0.73
multiple chemical sensitivity [MCS]	0.6		0.6
Multiple Sclerosis	3.3	1	2.3
Multiple system atrophy (MSA)	0.7		0.7
myasthenia gravis	0.7	0.2	2.5
neuropathic pain	0	0.5	0
Neuropathy (all types)	0.3	0.5	-0.67
neuropsychiatric disorders (PANDAS, PANS)	0.8		0.8
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic	2.1	0.5	3.2
NonCeliac Gluten Sensitivity	0.6	0.3	1
Obesity	4.2	2.8	0.5
obsessive-compulsive disorder	2.6	1.2	1.17
Osteoarthritis	2.1	0.5	3.2
Osteoporosis	0.9	0.5	0.8
pancreatic cancer	0.6	0.2	2
Parkinson's Disease	3.4	2.2	0.55
Polycystic ovary syndrome	2.9	0.9	2.22
Postural orthostatic tachycardia syndrome		0.1	-0.1
Premenstrual dysphoric disorder	0.3	0.1	2
primary biliary cholangitis	0.2	1.3	-5.5
Primary sclerosing cholangitis	1.5	0.8	0.88
Psoriasis	1.4	0.6	1.33
rheumatoid arthritis (RA),Spondyloarthritis (SpA)	3.3	1.1	2
Rosacea	0	0.2	0
Schizophrenia	2.2	0.6	2.67
scoliosis	0.6	0.3	1
Sjögren syndrome	0.8	1	-0.25
Sleep Apnea	0.5	0.5	0
Slow gastric motility / Gastroparesis	0.8		0.8
Small Intestinal Bacterial Overgrowth (SIBO)	1.2		1.2
Stress / posttraumatic stress disorder	1.4	1	0.4
Systemic Lupus Erythematosus	2.4	0.5	3.8
Tic Disorder	0.7	0.3	1.33
Tourette syndrome	0.2	0.3	-0.5
Type 1 Diabetes	1.9	1.1	0.73
Type 2 Diabetes	5.1	2.7	0.89
Ulcerative colitis	2.6	2.2	0.18
Unhealthy Ageing	2.7	0.4	5.75
Vitiligo	0.8	0.3	1.67

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]